Proteomics in Small Cell Lung Cancer

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: 1

Enrollment: 50

Sponsor: Aalborg University Hospital

Summary

The aim of this study is to gather insight into tumor-derived circulating extracellular vesicles-proteins in patients with newly diagnosed small cell lung cancer.

Eligibility Criteria

Inclusion Criteria:Written and signed informed consentHistopathologically and/or cytologically newly-diagnosed SCLCMeasurable disease on CT scansEligibility to receive standard chemotherapy consisting of carboplatin and etoposideExclusion Criteria:Active biopsy-verified second malignancy other than non-melanoma skin cancer or cervical carcinoma in situPrior treatment for any malignant diseases other than non-melanoma skin cancer and cervical carcinoma in situConcomitant anticoagulation treatment (acetylsalicylic acid and clopidogrel are allowed)Treatment with any other investigational agent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05623956). StuddyBuddy aggregates publicly available trial information.